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Abstract
Given the differences in the dopamine neurotransmission between the shell and the core of the nucleus accumbens, as well as 
the differential involvement of these two domains in oral behaviour of rats, it was decided to determine whether or not dopamine 
Dj an d /o r  dopamine D 2 receptors differentially direct oral behaviour in these two domains in rats. Intra-accumbens injections 
of the dopamine D, receptor agonist ( + )-6-chloro-7,S-dihydroxy-3-alIyl-1 -phenyl-2,3,4,5-letrahydro-l/7-3-benzazepine (SKF 
82958: 5 jiig/0.2 /¿I), the dopamine D 2 receptor agonist quinpirole (10 ju,g/0.2 ¡j. 1) and their combination were used to assess the 
role of these accumbens domains in jaw movements of rats. The present study shows that the combined administration of SKF 
82958 and quinpirole into the shell, but not the core, of the nucleus accumbens produced a highly significant increase in jaw 
movements, when doses which per se were nearly ineffective, were injected. This effect was fully inhibited by prior administra­
tion of either the dopamine D [ receptor antagonist 7M +  )-7-chloro-8-hydroxy-3-methyl-l-phenyl-2,3,4,5-tetrahydro-l //-3-be- 
nzazepine (SCH 23390: 0.5 ¿¿g/0.2 ¡Mg) or the dopamine D 2 receptor antagonist (-)-su lp iride  (25 ng/0.5  /xl) into the same 
region. It is concluded that dopamine D, and D 2 receptors in the shell, but not the core, of the nucleus accumbens are involved 
in jaw movements of the rat, providing the first piece of evidence that dopamine Dj and D 2 receptors in the shell o f  the nucleus 
accumbens mediate a particular behaviour.
Keywords: Nucleus accumbens, shell, core; Dopamine Dj receptor; Dopamine D 2 receptor; SKF 82958; Quinpirole; SCIi 23390; 
(-)-Sulpiride; Jaw movement; (Rat)
1. Introduction
The nucleus accumbens is considered a neural inter­
face between the limbic system and the extrapyramidal 
system (Mogenson and Yim, 1981; Cools, 1988). Today, 
evidence suggests that it is involved in the reinforcing 
effects of drugs as well as in the programming of 
ongoing behaviour. For example, decreases in self-ad­
ministration of psychostimulants have been observed 
after intra-accumbens injections of dopamine D 2 re­
ceptor antagonists, suggesting that this structure plays 
a critical role as neuroanatomical substrate for drug 
reinforcement in rats (Robledo et al., 1992). Also, 
recent data show that the combined injection of the 
dopamine D, receptor agonist SKF 38393 together
* Corresponding author. Fax 31.080.540044.
with the dopamine D2 receptor agonist quinpirole into 
the nucleus accumbens enhances oral behaviour in rats 
(Koshikawa et al., 1990; Prinssen et al., 1992; Koene et 
al., 1993). This suggests a critical role as neuroanatomi­
cal substrate for oral behaviour in rats.
Recently, it has become evident that the nucleus 
accumbens is a heterogeneous structure. At least two 
different parts can be discerned: the shell and the core 
(Voorn et al., 1986; Groenewegen et al., 1987; Heimer 
et al., 1991; Zahm and Brog, 1992; Brog et ah, 1993; 
Meredith et al., 1993; Jongen-Relo et al., 1994). The
shell and the core appear to be innervated by different 
sets of dopaminergic neurons (Voorn et al., 1986; 
Zahm, 1991, 1992). The shell contains a richer 
dopamine plexus than the core (Voorn et al., 1986), 
and the concentration of dopamine in the shell is 
higher than that in the core (Deutch and Cameron,
1992). The shell is less vulnerable to the neurotoxic
0014-2999/9 5 /$ 0 9 .5 0  © 1995 Elsevier Science B.V. All rights reserved 
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6-hydroxydopamine than the core (Deutch and 
Cameron, 1992). The dopamine turnover in the shell is 
more sensitive to restraint stress than that in the core, 
whereas the dopamine utilization in the shell is less 
sensitive to haloperidol than that in the core (Deutch 
and Cameron, 1992). Furthermore, the dopamine D  ^
binding in the rostral areas of the nucleus accumbens 
appears to be higher in the shell than in the core, 
whereas the dopamine D 2 binding appears to be lower 
in the shell than in the core (Bardo and Hammer, 
1991; Jongen-Relo et al., 1992). These data suggest 
that functional differences in the dopamine neuro- 
transmission occur in the two domains. Indeed, elec- 
trophysiological studies show that the synaptic trans­
mission is differentially modulated by dopamine in the 
shell and the core (Pennartz et a3., 1992).
Recent lesion studies suggest that especially the 
shell may be important in processing the reward rein­
forcing actions of psychostimulants such as cocaine 
(Robledo and Koob, 1993). In addition, recent studies 
on oral behaviour suggest that especially the shell plays 
a critical role as neuroanatomical substrate for oral
behaviour (Cools et ah, 1993; Prinssen et al., 1994).
Given the differences in the dopamine neurotrans­
mission between the shell and the core, as well as the 
differential involvement of these two domains in oral 
behaviour, the purpose of the present study was to 
determine whether or not dopamine Dj an d /o r 
dopamine D2 receptors differentially modulate oral 
behaviour in these two domains. Since previous studies 
have shown that intra-accumbens administration of a 
highly specific dose combination of the dopamine Dj
receptor agonist (±)-l-phenyl-2,3,435-tetrahydro-(l ƒƒ)- 
3-benzazepine-7,8-diol (SKF 38393: 5 /Mg) and the 
dopamine D 2 receptor agonist quinpirole (10 ju.g) was 
necessary for eliciting a well-defined type of jaw move­
ments marked by muscle-specific electromyographic 
activities of the anterior digastric and masseter muscle 
(Koshikawa et al., 1991a), this combination of doses 
was chosen for the present study. The volume, how­
ever, was reduced from 0.5 /¿I to 0.2 /xl in order to 
limit the diffusion to the chosen domains as good as 
possible. The dopamine Dj receptor antagonist SCH 
23390 and the dopamine D2 receptor antagonist ( — )- 
sulpiride were used to study the possible involvement 
of dopamine D1 and D2 receptors in the effects ob­
served.
Recording of jaw openings by means of a light-emit­
ting diode attached to the mandible of anaesthetized 
rats was used to analyze the effects of dopaminergic 
agents upon oral behaviour. This method has been 
found to be a valid method for studying the anatomical 
and pharmacological substrate of apomorphine-in- 
duced jaw movements. This method has provided reli­
able data about the nature of the functional interaction 
between dopamine D, and D2 receptors in apomor-
phine-induced jaw movements (Koshikawa et al., 1990), 
and it has provided detailed information about the 
differential involvement of the nucleus accumbens, the 
dorsal and ventral striatum as well as the globus pal- 
lidus in apomorphine-induced jaw movements 
(Koshikawa et al., 1990, 1991a,b).
2. Materials and methods
2.1. Surgical procedures
Male Sprague-Dawley rats (260-330 g) were anaes­
thetized with ketamine HC1 (10 mg/kg i.p.), supple­
mented during surgery with halothane (0.5-4% when 
appropriate). The surgical and recording procedures 
were as described previously (Koshikawa et al., 1990). 
A small light-emitting diode was feed to the mandible, 
and the animal held in a stereotaxic frame so that the 
head was fixed in constant relation to a light-sensitive 
transducer which detected the vertical movements of 
the diode. The spinal cord was transected at Cl level 
to confine drug-induced movements to the head re ­
gion, jaw movements were recorded on a polygraph for 
later quantification: jaw movements were counted au ­
tomatically with a spike trigger. The registration period 
lasted 240 min. Guide cannulas were implanted bilater­
ally into the shell or into the core of the nucleus 
accumbens according to previously described proce­
dures (Prinssen et al., 1994). The coordinates based on 
the atlas of Paxinos and Watson (1986) were: anterior 
= 10.6 mm, lateral = 0.5 mm, vertical = 8.0 mm (shell); 
anterior = 10.6 mm, lateral = 1.2 mm, ventral =  7.0 mm 
(core). Cannulas (0.5 mm o.d., 0.3 mm i.d., 6.0 m m  
length) directed at the shell were angled 21 degrees» 
and cannulas directed at the core were angled 18 
degrees from the mid sagittal plane to avoid the ven­
tricular system. The injection volume which was 0.2 ¡jl 1 
per side unless otherwise indicated, was delivered over 
a 20 s period, and the needle was left in situ for an  
additional 20 s period after completion of the injection. 
To minimize potential damage to the target site by th e  
implanted guide cannula the vertical coordinates of th e  
tip were chosen dorsal to the intended site of injection; 
the injection needle, 31-gauge stainless steel, was ex­
actly 1.2 mm (for the core) or 2.0 mm (for the shell) 
longer than the implanted guide cannula. After surgery, 
animals were maintained under anaesthesia by contin­
uous infusion of ketamine (10 m g/h i.v.). Lignocaine 
HC1 (2%) gel was applied to all incisions, and the  
rectal temperature was maintained at 37°C with a 
thermostatically controlled heating pad.
2.2. Drugs
The animals (n = 6-12 per experiment) received 
bilateral injections of the dopamine D  ^ receptor ago-
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nist SKF 82958 hydrochloride (5 /xg; Research Bio- 
chemicals), the dopamine D 2 receptor agonist quinpi- 
role (10 jig] Research Biochemicals) or their combina­
tion (cocktail); control animals received the solvent, 
namely saline. In an additional set of experiments the 
dopamine receptor antagonist SCH 23390 maleate 
(0.5 /¿g/0.2 fi\, n = 6; Schering) was given 10 min prior 
to the SKF 82958-quinpirole mixture in order to assess 
the contribution of dopamine Dj receptors to the ef­
fects observed. In two final sets of experiments intra- 
accumbens injections of the selective dopamine D2 
receptor antagonist ( — )-sulpiride (25 ng/0.2 ¿¿1, n = 6; 
25 ng/0.5 jitl, n == 6; Ravizza) were given 30 min prior 
to the combination of SKF 82958 and quinpirole in 
order to assess the contribution of dopamine D 2 recep­
tors to the effects observed. Doses and time schedule 
were based on previously published studies (Koshikawa 
et al., 1990; Prinssen et al., '1992; Koene et aL, 1993).
Animals were used only once.
At the end of the experiments, rats were deeply 
anaesthetized with pentobarbitone Na, perfused trans- 
cardially with 10% formaldehyde solution, and the 
brains were removed. Injection sites were identified 
from 50 jxm coronal sections stained with Nissl. Data 
were analyzed for only those animals in which the 
injections were correctly placed.
2.3. Statistical analysis
All values are expressed as means ± S.E.M. The 
effects were analyzed with a two-way analysis of vari­
ance (ANOVA) with a mixed design for repeated mea­
sures in time, including the univariate ANOVA test 
with ‘Greenhouser-Geisser Epsilon’ correction for the 
factor time.
3. Results
3.1. Effects of the combined injection o f SKF 82958 and 
quinpirole into the core and the shell of the nucleus 
accumbens
Fig. 1 (left side) gives a survey of the core and shell 
region in which the injection sites were located; data of 
rats with injection sites outside the arced region were 
discarded in the analysis (n = 35). Fig. 1 (right side) 
provides all injection sites in the shell of rats treated 
with the cocktail of SKF 82958 and quinpirole (upper 
part) and all injection sites in the core of rats treated 
with this cocktail (lower part).
The overall effects of saline (control; n = 6/core; 
n = 7/shell), SKF 82958 (n =  6/shell), quinpirole 01 = 
6/shell) and their combination (n = 6/core; n ~ 
6/shell) are shown in Fig. 2. The combined administra­
tion of SKF 82958 and quinpirole was ineffective, when
injected into the core: the number of jaw movements in 
the treated rats did not significantly differ from that in 
solvent treated animals (F(l,10) = 0.10, P — 0.76). 
Since previous studies have shown that these drugs 
only potentiate, but not counteract, each other’s effects 
after administration into the nucleus accumbens and, 
in addition, have no effects per se after administration 
into the nucleus accumbens (Koshikawa et al., 1990), 
no attempts were done to investigate the effects of 
injections of each drug separately into the core. In 
contrast, the combined injection of SKF 82958 and 
quinpirole was highly effective, when injected into the 
shell: the number of jaw movements was significantly 
greater than that found in solvent-treated rats (^(1,11) 
= 24.34, P < 0.001). When given alone in the same 
dose, SKF 82958 remained ineffective following injec­
tions into the shell: the number of jaw movements in 
the SKF-treated rats did not differ from that found in 
solvent-treated rats ( F ( l , l l )  = 2.92, P = 0.12). The 
number of jaw movements in quinpirole-treated rats, 
however, was significantly greater than that found in 
solvent-treated rats ( H i ,  11) = 10.01, P <  0.009); how­
ever, Figs. 2 and 3 show that there was only a minor 
increase. Comparing the effects of the combined treat­
ment with the effects of each single drug resulted in a 
highly significant difference (SKF 82958 -f quinpirole 
versus quinpirole: F(1,1Q) -  10.16, P < 0.01; SKF 
828958 + quinpirole versus SKF 828958: F(l,10) — 
15.27, P < 0.003).
The time-dependent effects of the combined injec­
tions of SKF 82958 and quinpirole into the core re­
spectively the shell are shown in Fig. 3. This figure 
clearly shows that the effect started nearly immediately 
after the injection into the shell, reached its peak 
around 60 min and vanished about 120 min after the 
injection: apart from the fact that there was a signifi­
cant drug effect (see above), there was a significant 
time effect (F (9,99) = 5.99, P < 0.001) as well as a 
significant interaction between the factor drug and the
factor time (F(9,99) =  5.75, P < 0.001).
3.2. Effects o f SCH 23390 and ( —) -sulpiride upon jaw 
movements elicited by the combined administration o f 
SKF 82958 and quinpirole into the nucleus accumbens
Injections of SCH 23390 (0.5 fig) into the shell 
significantly attenuated the shell effects of the cocktail 
of SKF 82958 and quinpirole (Fig. 4; F(9,99) = 3.60, 
P < 0.001; n — 6).
Injections of ( — )-sulpiride (25 ng) into the shell 
significantly attenuated the shell effects of the cocktail 
of SKF 82958 and quinpirole only, when ( — )-sulpiride 
was dissolved in 0.5 /¿I (Fig. 4; F(l,10) = 6.68, P < 0.03; 
n = 6). Such injections remained ineffective, when 25 
ng (-)-sulpiride was injected in a volume of 0.2 ¡i\ 
(F(l,10) = 1.18, P  < 0.3; n = 6). However, this treat-
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Fig, Right side: the regions in which all injection sites were located for the shell (upper part) and the core (lower part). Left side: all sites 
found after injections of the mixture of SKF 82958 and quinpirole into the shell (upper part) and the core (lower part).
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Fig. 2. The effect of injections of saline, 5 fxg SKF 82958, 10 ¡jlq quinpirole and the mixture of 5 /xg SKF 82958 and 10 ¡ig quinpirole in to  the 
shell and the core of the nucleus accumbens (0.2 /x 1/side). The number of jaw movements observed during the period of 240 min a f te r  the 
injections (means ±  S.E.M.) is given, P  < 0.05.
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Fig. 3. T h e  time-dependent effects of injections of saline, 5 j i g  SKF 
82958, 10 f ig  quinpiroie and the mixture of SKF 82958 and quinpi­
roie into the shell of the nucleus accumbens (0.2 ^ I / s id e ) .  The 
num ber of jaw movements observed per 5 min (m eans±S .H .M .)  is 
given.
ment produced a reduction in two of the six tested rats; 
the mean number of jaw movements in these two rats 
was 858 ± 84, whereas the mean number of jaw move­
ments in the remaining four rats was 4851 ±  138. Histo­
logical analysis showed that the two effective sulpiride 
injections were placed in the ventromedial part of the 
shell (coordinates according to the atlas of Paxinos and 
Watson (1986): interaural plane: 10.7; bregma: 1.7; 
vertical: 2.3).
4. Discussion
The outcome of the present study confirms the 
earlier reported finding that the shell, but not the core, 
of the nucleus accumbens is involved in the control of
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Fig. 4. T h e  effect of 0.5 ¡ig SCH 23390(0.2 /xI per side), given 10 min 
prior lo the mixture of 5 f ig  SKF 82958 and 10 f ig  quinpiroie (open 
squares) and that of 25 ¿¿g ( - )-sulpiride (0,5 fi 1 per side), given 30 
min prior to the same mixture (0.2 p, 1/side; closed circles): all 
injections were made into the shell of the nucleus accumbens. The 
num ber o f  jaw movements observed per 5 min (means ± S .E .M .)  is 
given. Control -  effect of the mixture of SKF 82958 and quinpiroie 
(closed squares).
oral behaviour, especially jaw movements (Borcli et al., 
1989; Cools et al., 1993; Prinssen et al., 1994): the 
combined administration of SKF 82985 and quinpiroie 
was only effective when injected into the shell, but not 
the core, of the nucleus accumbens. The finding that 
especially the shell of the nucleus accumbens is in­
volved in oral behaviour is understandable in view of 
the fact that the shell projects to a part of the ventral 
pallidum, that is known to be involved in oral be­
haviour (Spooren et al., 1989).
Although the full dopamine D 1 receptor agonist 
SKF 82958 has some anomalous properties in certain 
assays (Murray and Waddington, 1989; Mottola et al., 
1992; O’Boyle et al., 1989), both the dopamine D, 
receptor agonist SKF 38393 which lacks these anoma­
lous properties, and the dopamine agonist SKF 
82958 produced similar effects when combined with 
quinpiroie (Koshikawa et al., 1990; Prinssen et aL, 
1992; Koene et al., 1993). This together with the find­
ing that the dopamine D, receptor antagonist SCH 
23390 antagonized the effects of the SKF 82958- 
quinpirole cocktail provides evidence that dopamine 
D 3 receptors were involved. Quinpiroie, however, is a 
dopamine receptor agonist that has a high affinity not 
only for dopamine D2 receptors (Stoof and Kebabian, 
1981), but also for dopamine D3 receptors (Sokoloff et 
al., 1990). For that reason, we analyzed the ability of 
the highly selective dopamine D 2 receptor antagonist 
( — )-sulpiride (Spano et aL, 1979) to inhibit the effects 
seen. As shown in Fig. 4, ( —)-sulpiride did inhibit the 
effects. As mentioned in the Results section, ( —)- 
sulpiride was effective in all rats when injected in a 
volume of 0.5 /x 1, but effective only in two out of six 
rats when injected in a volume of 0,2 jjlL Since the 
latter injections were located in a circumscribed part of 
the shell, these data suggest that (-)-su lp iride  did not 
really diffuse, implying that this drug is an extremely 
useful tool in studies on the delineation of critical 
regions in the brain. Anyhow, the observation that 
(-)-su lp iride  inhibited the effects of SKF 82985 and 
quinpiroie provides evidence that dopamine D 2 recep­
tors were involved as well. It has to be noted that this 
does not mean that dopamine D3 receptors play no 
role in this respect: future studies are necessary to 
establish their role in this respect.
Previously, we and others have reported that 
dopamine D, receptor agonists and dopamine D2 re­
ceptor agonists have similar or opposite effects which 
are additive or antagonistic depending on the be­
haviour studied (Koene et al., 1993; Waddington, 1993). 
Concerning jaw movements elicited by intra-accumbens 
injections of these agents, it has been reported that 
administration of just one of these agonists being ei­
ther SKF 38393 or quinpiroie has no significant effect 
on jaw movements, excluding thereby the possibility to 
study possible counteracting effects in this respect.
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Thus, the present data show that combined stimulation 
of dopamine Dj and D2 receptors produces additive 
effects on jaw movements when injected into the shell 
of the nucleus accumbens.
The present data clearly show that the differences in 
the dopamine neurotransmission between the shell and 
the core of the nucleus accumbens which are men­
tioned in the introduction section have direct conse­
quences for the function of dopamine in these two 
domains: dopamine Dj and D 2 Teceptors in the shell, 
but not in the core, modulate the display of jaw move­
ments in the rat. To what extent these receptors also 
mediate the reward reinforcing effects of psychostimu­
lants remains to be investigated.
In sum, the present study provides the first piece of 
evidence that the dopamine D1 and D2 receptors in 
the shell, but not the core, are involved in the control 
of jaw movements in the rat.
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